ViiV rolls out long-acting HIV campaign targeting 'future you'
|
HIV
drugmaker ViiV Healthcare is helping prospective HIV prevention or
treatment users to make a choice that will help them later down the line
in ... |
BioNTech Launches mRNA HIV Vaccine Trial
... antiretroviral therapy for at least 12 months will receive four injections. Enrollment will span participants aged 18 to 50 years; those with HIV ... View article...